Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody–drug conjugates
Xuefei Bai(Zhejiang University), Liqiang Pan(Zhejiang University)
Cited by 2
Related Papers
Emerging new therapeutic antibody derivatives for cancer treatment
|Signal Transduction and Targeted Therapy|2022|432
Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance
|Nature Communications|2022|17
A general pHLA-CD80 scaffold fusion protein to promote efficient antigen-specific T cell-based immunotherapy
|Molecular Therapy Oncology|2024|1